Literature DB >> 32309040

Progressive supranuclear palsy and pawpaw.

Bonnie Kaas1, Argye E Hillis1, Alexander Pantelyat1.   

Abstract

Entities:  

Year:  2020        PMID: 32309040      PMCID: PMC7156197          DOI: 10.1212/CPJ.0000000000000704

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


× No keyword cloud information.
  7 in total

1.  Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.

Authors:  D Caparros-Lefebvre; A Elbaz
Journal:  Lancet       Date:  1999-07-24       Impact factor: 79.321

2.  Atypical parkinsonism and Annonaceae consumption in New Caledonia.

Authors:  Gilles Angibaud; Claude Gaultier; Olivier Rascol
Journal:  Mov Disord       Date:  2004-05       Impact factor: 10.338

3.  Experimental evidence for a toxic etiology of tropical parkinsonism.

Authors:  Günter U Höglinger; Patrick P Michel; Pierre Champy; Jean Feger; Etienne C Hirsch; Merle Ruberg; Annie Lannuzel
Journal:  Mov Disord       Date:  2005-01       Impact factor: 10.338

4.  Annonacin in Asimina triloba fruit: implication for neurotoxicity.

Authors:  Lisa F Potts; Frederick A Luzzio; Scott C Smith; Michal Hetman; Pierre Champy; Irene Litvan
Journal:  Neurotoxicology       Date:  2011-11-23       Impact factor: 4.294

5.  Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?

Authors:  Annie Lannuzel; G U Höglinger; S Verhaeghe; L Gire; S Belson; M Escobar-Khondiker; P Poullain; W H Oertel; E C Hirsch; B Dubois; M Ruberg
Journal:  Brain       Date:  2007-02-15       Impact factor: 13.501

6.  The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.

Authors:  A Lannuzel; P P Michel; G U Höglinger; P Champy; A Jousset; F Medja; A Lombès; F Darios; C Gleye; A Laurens; R Hocquemiller; E C Hirsch; M Ruberg
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

7.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Authors:  Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan
Journal:  Mov Disord       Date:  2017-05-03       Impact factor: 10.338

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.